chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle spasms; feeling fatigue; recurring headaches; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasms), FATIGUE (feeling fatigue), HEADACHE (recurring headaches) and MYALGIA (sore arm) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03421A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN for Hypercholesteraemia, LOSARTAN for Hypertension.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (muscle spasms), FATIGUE (feeling fatigue), HEADACHE (recurring headaches) and MYALGIA (sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (muscle spasms), FATIGUE (feeling fatigue), HEADACHE (recurring headaches) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
pt recv vax 10JAN96&24JAN96 pt devel a rash w/12 small blisters on limbs,not @ the inj site;no further details were provided;
Day 1: the patient talked about redness and soreness at the injection site. Day 2: patient talked about nerve pain down the arm side that swelled up. The swelling and pain lasted about a week.  Patient took ADVIL to ease the pain which only worked a little. Patient has had shingles in the past (11/2016) and she explained this nerve pain as being similar to the shingles pain in the past. Ultimate treatment/cure was with laser treatment from the chiropractor. The pain subsided and eventually went away. Will do further research to see if patient should receive second vaccine.
Severed joints pain, lower back pain,  tiredness, swollen armpit lymph nodes, lacked of  right arm movement.
Red, raised bumps to trunk of body within an hour of receiving immunizations. Treated with Benadryl by mouth.
Vomiting, headaches, general aches, feverishness, sciatic pain. Abdominal pain. Continues to feel nauseated, lazy, & weak.
Immediately after, I experienced achiness in bilateral arms, which was expected. However, 4 hours following the vaccination, I started experiencing fever, chills, and additional muscle aches. Tylenol 500mg 2 tablets in the early evening and Ibuprofen 2 tablets before bed improved symptoms slightly. The next morning/today, I awoke with more fever, chills, muscle aches, accompanied by dyspnea and what appears to be lymphangitis in the left deltoid to the axilla.
Blurry Vision 5 minutes after shot administered. Warming sensation spread throughout my chest. It felt like a chain reaction within the muscle layer of my chest. It traveled outward and into my left arm and up towards my neck. Face  became a little itchy. The sensation last for about  1 to 2 minutes then it subsided. After and an additional 5 minutes the warming sensation began again from the same locations. A traveling warming sensation began to spread in my chest. At that point the decision was made to call 911 for further evaluation. The paramedics assessed that my blood pressure was elevated, abut that oxygen vitals were good. It was determined I would not need further intervention and to go home and rest and take some Benadryl as a precaution.  On the way home, I got the warming sensation again this time on my abdomen.  And it passed after a few minutes.
a slight temperature after the first shot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 09Jan2021 15:00 (Lot number: EL1283) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "a slight temperature after the first shot". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Headache, Fever, NauseaVomiting, "FLU LIKE SYMPTOMS" Narrative:
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/20/20 2nd dose01/09/21 Diagnosed covid positive:09/06/21 Symptom onset:09/02/21 Exposure:community Symptoms:fever, SOB, cough,fatigue,muscle aches, loss of taste,sorethroat,nausea,diarrhea,chilLs,runny nose ,HA.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 59-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "bronchitis" (unspecified if ongoing); "asthma" (unspecified if ongoing). There were no concomitant medications. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 03May2022, outcome "unknown" and all described as "experienced some symptoms of Covid and tested positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03May2022) positive. Clinical information: Caller states she was done with the Paxlovid on Wednesday and felt much better and as of Sunday she started feeling the same symptoms of a little breathlessness, coughing, and some congestion overall, and took a test again, and was back to being completely positive, and was extremely careful, and there was no way that she got it a 2nd time. Caller states she began having symptoms of a little breathlessness, coughing and some congestion and that began on Sunday 01May2022 and those symptoms are ongoing and she had started taking Paxlovid almost immediately after the symptoms began and started the Paxlovid on 22Apr2022 and finished the Paxlovid on 27Apr2022 and she would say she did not get very far before she took the Paxlovid and her symptoms that began on Sunday are ongoing and about the same. States her symptoms may be a little bit less and she has not taken her fever or temperature today and does not think she is feverish. Description of Product Complaint: Description of complaint: Caller states she tested positive for Covid and took that test today 03May2022; as of Sunday she started feeling the same symptoms of a little breathlessness, coughing, and some congestion overall and took a test again and was back to being completely positive; Caller states for the lot number for Paxlovid, she has to go get her glasses which are her reading glasses. Caller states she has one question that nobody asked and for what it is worth she was totally vaccinated and boosted and this was a breakthrough of that and confirmed she had received the Pfizer Covid vaccine; caller states she has no dates of vaccine administration, lot numbers, expiry dates or NDC numbers to provide at this time as she would have to go find her card and it is not with her at this time. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial: rigors, body aches, nausea, headache  After one months, onset of migraines nearly every three weeks, increase in menstration, reynauds in fingertips when exposed to cold, generalized pruritis without rash
Patient developing bacteremia after receiving the Moderna COVID-19 vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACTERAEMIA (Patient developing bacteremia after receiving the Moderna COVID-19 vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACTERAEMIA (Patient developing bacteremia after receiving the Moderna COVID-19 vaccine.) (seriousness criterion medically significant). At the time of the report, BACTERAEMIA (Patient developing bacteremia after receiving the Moderna COVID-19 vaccine.) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No concomitant medications were reported.  No treatment information was provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient reports that her arm started feeling "stiff" and difficult to raise several hours after the shot. Claims it has become difficult to raise her arm above shoulder level. Reports flat, pink rash/discolored patch about 4" in diameter around injection site developed at some point during the night of injection. Rash does not itch, burn, or hurt. Presented to pharmacy on 3/13 and wanted us to be aware/document and suggest if she should follow up with provider. At that time pharmacist on duty noted rash as described above, but color was more faded than original day, according to patient. Verified rash was local to injection site, patient had no systemic symptoms, and advised patient to follow up with provider if mobility continued to be an issue or symptoms worsened/did not resolve.
This spontaneous report was received from a physician via field representative, refers to a 12 month old patient. On an unknown date the patient was vaccinated with M-M-R II (lot # J014875 and expiration date was 21-NOV-2015) subcutaneous . Concomitant therapies included (Oka/Merck) VARIVAX, PREVAR, hib conj vaccine (unspecified carrier) (manufacturer unknown) and influenza virus vaccine (manufacturer unknown). On 10-OCT-2014 the patient experienced node at the injection site "MMR-like" rash over the back and trunk area (not specified if the patiens rash resembled measles, mumps, or rubella specifically). Patient sought medical attention by visiting doctor. No Produce Quality Complaint (PQC) was involved. The outcome of events was reported as not recovered/not resolved. Causality was not provided by the reporter.  Additional information has been requested.
Shortly after I received the vaccination my menstrual cycle started early and was extremely heavy. Oct 9th I passed 2 clots that were slightly larger than a quarter and several penny sized clots. I?ve never had this happen in any of my other cycles my entire life. My cycle lasted for 4 days then subsided. I only passed clots on the first day of my cycle (10/9/21).
Within 2-3 hours of receiving flu mist vaccine pt erupted with an exanthematous light pink rash covering the lower torso and legs - not pruritic or urticarial. Mostly resembles a viral exanthem.
Within hours she started stuttering by Friday she couldn't get a word out without getting stuck on the word. By Monday it was getting better, it's gradually gotten better but she still stutters on words. Of course I called the doctor and he said it was not listed as a side effect and at her age because she's so advanced her brain is not being able to keep up with her vocabulary. But I don't believe that it just so happened.
Information has been received from a nurse concerning a female who on 26-APR-2008 was vaccinated intramuscularly with a third dose of GARDASIL (lot # not reported). The nurse reported that the patient received the dose in the morning and in the afternoon, she complained of hives that appeared from her neck up. The patient sought medical attention during a phone call to the physician. Additional information has been requested.
I am a breakthrough case and developed symptoms from Covid-19 on 12/18/2021. I had a bad sinus infection. My nose kept on running and draining. I had a fever of 103. I had chills and I was coughing.
Pt recv vax on 12/29/98; on 1/25/99 pt exp stiff neck & LA pain/ weak
Vaccine administered after temperature excursion; This spontaneous report was received from a physician referring to a patient of unknown age and gender.    Information regarding the patient's  concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 28-JUL-2020, the patient was vaccinated with an improperly stored dose  of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T002843 (expiration date 23-JAN-2022) and lot # S032357 (expiration date 14-OCT-2021) 0.5 milliliters for prophylaxis (strength, frequency and route of administration were not reported).  Other suspect therapies included measles, mumps, rubella and varicella (oka-merck) virus vaccine live of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant Human albumin)  (PROQUAD) lot # T009929 (expiration date 16-SEP-2021) and  lot # S031882 (expiration date  07-APR-2021) for prophylaxis (strength, dose, frequency, and route of administration were not reported). .  The improperly stored vaccines experienced all an intermitent temperature excursion between -14 degree Celsius (°C) to 10°C (max -9.5°C) for 38 hours and 30 minutes with no previous temperature excursion.  The call was made due to a digital data logger. No adverse symptoms were reported.  This is one of several cases from the same reporter.
pt was given monovalent vaccine rather than bivalent pt returned later that day to get bivalent
11 days after the shot, I developed a red itchy  rash with swelling.   I woke up that morning with a sinus headache, had diarrhea, then at night the rash started.  The next day, I was sick with headache, exhausted,  no appetite.  Today is day three - the rash is bigger, but I am not as sick as I was yesterday, though still tired, and no appetite, and a little nauseous.
Numbness in hands and Feet feels like carpel tunnel; Frustrated; Chills after second Shot; Tired after second Shot; Nauseous after second Shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in hands and Feet feels like carpel tunnel), FRUSTRATION TOLERANCE DECREASED (Frustrated), CHILLS (Chills after second Shot), FATIGUE (Tired after second Shot) and NAUSEA (Nauseous after second Shot) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Gestational diabetes.   On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced HYPOAESTHESIA (Numbness in hands and Feet feels like carpel tunnel), FRUSTRATION TOLERANCE DECREASED (Frustrated), CHILLS (Chills after second Shot), FATIGUE (Tired after second Shot) and NAUSEA (Nauseous after second Shot). On 24-Sep-2021, CHILLS (Chills after second Shot) had resolved. On 28-Sep-2021, FATIGUE (Tired after second Shot) and NAUSEA (Nauseous after second Shot) had resolved. At the time of the report, HYPOAESTHESIA (Numbness in hands and Feet feels like carpel tunnel) and FRUSTRATION TOLERANCE DECREASED (Frustrated) outcome was unknown.            The patient has 2 years old baby and still breastfeeding but baby has no issues.  No Concomitant medication was reported. No Treatment information was reported.   This case was linked to MOD-2021-339349 (Patient Link).
nausea within 1 day; then body aches and headaches that persisted for the next 2 weeks. i was so sick i decided to get tested and on April 1, i tested positive for Covid. as of today, 4/4/21 i have covid.
vision completely cleared up/after one month her vision slightly went back to having to wear her readers again to see up close.; sneezed for two days straight; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 68-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included underlining heart condition from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. On an unspecified date in Apr2021, the patient experienced sneezed for two days straight. On an unspecified date, experienced vision completely cleared up/after one month her vision slightly went back to having to wear her readers again to see up close. It was further stated by the reporter that my aunt and she called me to let me know when she took the second dose of the Pfizer COVID 19 vaccination that she sneezed for two days straight and then her vision completely cleared up for almost one month and she did not have to wear glasses to see up close anymore. She was reading the back of splendid packets for one month. And then after one month her vision slightly went back to having to wear her readers again to see up close. The patient which again is my aunt does have an underlining heart condition. The clinical outcome of the event sneezed for two days straight was reported as recovered on an unspecified date in Apr2021, while for the event vision completely cleared up/after one month her vision slightly went back to having to wear her readers again to see up close was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I had swelling on my hand, I had bruises on my arm, legs, back. Knots in my head the size of my fist. I had blisters on my thumb and hands. The lumps in my head would be large and itch. I had something like hives. Extreme dry skin. Left arm had verities. It was painful.
Dose 1 2/8/2021 Lot # EN5318 Pfizer.  Pt died in the hospital
Headache; BODY ACHES (SPECIFICALLY LOWER BACK); Chills; Sweating; Lack of appetite; Goosebumps; TIRED; SLEEPY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 21:00 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced headache. On 07-MAR-2021, the subject experienced body aches (specifically lower back). On 07-MAR-2021, the subject experienced chills. On 07-MAR-2021, the subject experienced sweating. On 07-MAR-2021, the subject experienced lack of appetite. On 07-MAR-2021, the subject experienced goosebumps. On 07-MAR-2021, the subject experienced tired. On 07-MAR-2021, the subject experienced sleepy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 07-MAR-2021, and the outcome of body aches (specifically lower back), chills, sweating, lack of appetite, goosebumps, tired and sleepy was not reported. This report was non-serious.
Approximately fist sized welt appeared and felt warm to the patient. Patient was informed to apply ice compresses. Follow up in 3 days and there were no residual effects of vaccination.
This spontaneous report has been received from a pharmacist referring to a 56 years old male patient. The patient did not have pertinent medical history. Patient's drug allergies included codeine. On 12-JUN-2017, the patient was vaccinated subcutaneously with ZOSTAVAX lot # M039453, expiration date 19-DEC-2017, 1 DF in the right arm for prevention of shingles. The vaccine was reconstituted with a sterile diluent (manufacturer unknown) lot # N007932, expiration date 06-MAY-2018. On 13-JUN-2017, the patient developed redness at the injection site. At the reporting time, the patient did not recover from the event. The relatedness between the injection site erythema and ZOSTAVAX was not provided.
The Hepatitis B vaccine for adults and pediatric use are very similar. Although they have different color bands on the syringes, the syringes are identical in shape and size. The writing on the syringe is also extremely small, making it difficult to read. The boxes are different colors, but the syringes taken out of the box when they are put into the pyria, so the colors aren't quite as obvious. It is very easy to pull out the wrong once since they are so similar and are hard to read.
Awoken with circumferential ecchymosis to L upper arm Also experienced mild lymphedema  .5 to 1 of L extremity  Reaction symptoms cleared in 36 hours  I suppose it?s COVID arm .
Patient came to office site to receive 2nd Covid vaccine. She completed consent form evaluated by nurse concerning consent form questions (Allergies, Health history) explained side possible side effects pt verbalized understanding administered vaccine IM/RA & advised pt to proceed next door to be monitored for 15 mins in which the pt started verbalizing she received previous vaccine a certain date which made her ineligiable to receive 2nd dose due to vaccine was given in error to soon (should have been 03/17/22) but info wasn't stated on consent form or vaccine card by registration person. Pt was then advised by a healthcare professional who monitored her that she would not received incentive card today because of this error and that she got could return om 03/17/2022 to obtain incentive card upon approval of staff. Pt Verbalized understanding and exited office in satisfactory condition with updated/correct vaccine care
Administered an expired Havrix; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 30-year-old female patient who received HAV (Havrix adult) (batch number 7YA99, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd October 2022, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 3rd October 2022, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 03-Oct-2022 Reporter's comment: The registered nurse called to inquire what to look for. The registered nurse reported that they inadvertently administered an expired Havrix. The reporter did not consented to follow up. Additional Supportive Information The patient was inadvertently administered an expired dose of Havrix, which led to expired vaccine used.
pt recvd vax 20oct94 & exp chest pain & was hosp; pt died same day;
From telephone conversation with reported, it was stated that a 4 year old (4 of4) was vacationed (sic) with Tripedia, lot UO356AA (date not specified). Some time after the vaccination, the patient developed a local reaction (date of onset specified). Further information is requested. Linked cases U200100950, U200100956 & U200100957
Low grade fever, stomach upset, chills, general malaise starting morning after and continuing for 24 hours.
Blood clotting, hospitalized, emergency, paralyzed, thrombosis, body not responding, therapy, treatment.